Jakub Knurek

Jakub Knurek is a Business Development Specialist at Mabion S.A. Jakub is also a Biotechnologist working with Novavax COVID-19 vaccine at RKAC Ltd. as well as the Chief Technology Officer and Co-Founder. Additionally, Jakub serves as the Editor in Chief and Publisher at Granice Wytrzymałości, while also working in production at Giant Bicycle and as a Dealer at IKEA Group. Jakub has a background in biology and biochemistry with a Master of Science degree from Uniwersytet Marii Curie-Skłodowskiej w Lublinie and is currently pursuing a Ph.D. in Pharmacy at Medical University of Lublin.